In October 2012, the American Society of Reproductive Medicine announced it no longer considers oocyte freezing experimental. This raises complex questions about how to counsel patients who wish to preserve eggs for social indications.
Uterine artery embolization for fibroids results in a tremendous reduction in menorrhagia. But while complication rates are low, up to 15% of patients are readmitted for indications like pain, bleeding and infection.
The Contraceptive CHOICE Project, a research study at Washington University in St. Louis, found that offering long-acting, reversible contraception (LARC) to women first, citing its low-failure rates, reduced rates of unintended pregnancy and abortion and increased continuation rates.
Diana Bianchi discusses noninvasive prenatal testing, including false positives and testing average-risk women, at ACOG's Annual Meeting.
“Using a prophylactic sling during prolapse repair significantly reduces postoperative stress incontinence,” said Anthony Visco, a representative of the American Urogynecologic Society at the 61st annual American Congress of Obstetricians and Gynecologists meeting.
In a randomized study of 249 women treated for urge incontinence, Botulinum toxin A (Botox) reduced episodes from an average of 5 per day to 3.3 per day, equal to standard anticholinergic treatment.
Hormones, particularly transdermal estradiol, may help women maintain mood, cognition and memory in middle-age and beyond. “What we have learned the past decade is that not all estrogens are the same,” said ACOG presenter Sarah Berga, MD, of Women’s Health at Wake Forrest School of Medicine, “and that the differences can be critical.”
Many ob/gyns and nurse practitioners see vulvovaginal disease on a day-to-day-basis, but lack the knowledge to accurately diagnose and treat them. At ACOG’s 61st Annual Clinical Meeting, Hope Haefner, MD, Department of Obstetrics and Gynecology at the University of Michigan, and Lynette Margesson, MD, Adjunct Assistant Professor of Obstetrics and Gynecology and Surgery (Dermatology) at the Geisel School of Medicine at Dartmouth, presented tips to help clinicians identify common and rare vulvar diseases.
One in seven women will experience pelvic pain in her lifetime, and between one- and two-thirds will have chronic pain that persists for more than three years. But although it’s common, it can be one of the most difficult and frustrating conditions physicians treat.